Luptakova Katarina 4
4 · Xilio Therapeutics, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Luptakova Katarina
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-01-01−16,625→ 49,875 total→ Common Stock (16,625 underlying) - Exercise/Conversion
Common Stock
2025-01-01+16,625→ 16,625 total - Award
Stock Option (right to buy)
2025-01-01+200,000→ 200,000 totalExercise: $0.95Exp: 2035-12-31→ Common Stock (200,000 underlying)
Footnotes (3)
- [F1]Restricted stock units ("RSUs) convert to stock on a one-for-one basis
- [F2]These RSUs were granted on January 1, 2024 and will vest in four equal annual installments beginning on January 1, 2025 and continuing through January 1, 2028.
- [F3]The option was granted on January 1, 2025 and will vest in 48 equal monthly installments beginning on February 1, 2025 and continuing through January 1, 2029.